News from the Greater Philadelphia life sciences industry this week includes details about a multi-million dollar purchase and a multi-million dollar license agreement, plus updates on experimental drugs to treat cancer and seizures. Here’s a summary: Chester County Specialty Pharmaceutical Subsidiary Endo Ventures Limited has acquired six ready-to-use injection candidates from Nevakar Injectables, a subsidiary of Nevakar Inc., for $ 35 million. . Purchase

By philcp

Leave a Reply

Your email address will not be published.